Literature DB >> 599936

Biochemical characteristics, metabolism, and antitumor activity of several acetylated hexosamines.

R J Bernacki, M Sharma, N K Porter, Y Rustum, B Paul, W Korythyk.   

Abstract

We have synthesized several potential inhibitors and/or modifiers of the carbohydrate portion of plasma membrane glycoconjugates. These include fluorinated and actylated analogs of D-glucosamine, D-galactosamine, and D-mannosamine. These compounds have been tested to determine their effects on both[14C] glucosamine and [3H] leucine incorporation into glycoconjugate and on cell growth and viability using P-288 murine lymphoma cells maintained in tissue culture. The most cytotoxic agent tested was 2-acetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-beta-D-glucopyranose or simply beta-pentaacetylglucosamine which prevented cell growth at 10(-4)-10(-3) M. beta-Pentaacetylglucosamine cytotoxicity was correlated with its high lipid solubility, having an octanol/water partition coefficient of 0.424 as compared with 0.278 for the alpha-anomer and 0.017 for N-acetylglucosamine. In vitro metabolism studies with [4C]- and/or [3H]-labeled pentaacetylglucosamine have indicated intracellular de-O-acetylation leading to the biosynthesis of UDP-N-acetylglucosamine, followed by the incorporation of this sugar into cellular glycoprotein. Concomitant with the formation of increased amounts of this nucleotide sugar, intracellular UTP and CTP pools fell to one third normal within 3 h after the administration of 1 mM pentaacetylglucosamine. At present it is unclear whether the cytotoxicity of beta-pentaacetylglucosamine or other similar agents is due to alterations in nucleotide and nucleotide-sugar pools causing a decrease in energy charge and polynucleotide biosynthesis or is due to a direct effect on membrane glycoconjugate biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 599936     DOI: 10.1002/jss.400070208

Source DB:  PubMed          Journal:  J Supramol Struct        ISSN: 0091-7419


  11 in total

1.  A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3).

Authors:  Xander M van Wijk; Roger Lawrence; Victor L Thijssen; Sebastiaan A van den Broek; Ran Troost; Monique van Scherpenzeel; Natasha Naidu; Arie Oosterhof; Arjan W Griffioen; Dirk J Lefeber; Floris L van Delft; Toin H van Kuppevelt
Journal:  FASEB J       Date:  2015-04-13       Impact factor: 5.191

Review 2.  Leveraging fluorinated glucosamine action to boost antitumor immunity.

Authors:  Charles J Dimitroff
Journal:  Curr Opin Immunol       Date:  2012-12-06       Impact factor: 7.486

3.  Regulation of heparan sulfate and chondroitin sulfate glycosaminoglycan biosynthesis by 4-fluoro-glucosamine in murine airway smooth muscle cells.

Authors:  Julie Nigro; Aimin Wang; Durba Mukhopadhyay; Mark Lauer; Ronald J Midura; Robert Sackstein; Vincent C Hascall
Journal:  J Biol Chem       Date:  2009-04-03       Impact factor: 5.157

4.  Metabolism of 3-deoxy-3-fluoro-D-mannose and 4-deoxy-4-fluoro-D-mannose by Saccharomyces cerevisiae S288C.

Authors:  T J Grier; J R Rasmussen
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

Review 5.  Glycosidases in cancer and invasion.

Authors:  R J Bernacki; M J Niedbala; W Korytnyk
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

6.  Incorporation of N-fluoroacetyl-D-glucosamine into hyaluronate by rabbit tracheal explants in organ culture.

Authors:  D J Winterbourne; R J Barnaby; P W Kent; N Mian
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

7.  Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis.

Authors:  Victor L Thijssen; Roger Lawrence; Xander M van Wijk; Sebastiaan A van den Broek; Margo Dona; Natasha Naidu; Arie Oosterhof; Els M van de Westerlo; Lisanne J Kusters; Yasmine Khaled; Tiina A Jokela; Patrycja Nowak-Sliwinska; Hannie Kremer; Sally E Stringer; Arjan W Griffioen; Erwin van Wijk; Floris L van Delft; Toin H van Kuppevelt
Journal:  ACS Chem Biol       Date:  2013-09-03       Impact factor: 5.100

8.  Inhibition of amyloid A amyloidogenesis in vivo and in tissue culture by 4-deoxy analogues of peracetylated 2-acetamido-2-deoxy-alpha- and beta-d-glucose: implications for the treatment of various amyloidoses.

Authors:  Robert Kisilevsky; Walter A Szarek; John B Ancsin; Elena Elimova; Sandra Marone; Shridhar Bhat; Ali Berkin
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

9.  Biological evaluation of a series of 2-acetamido-2-deoxy-D-glucose analogs towards cellular glycosaminoglycan and protein synthesis in vitro.

Authors:  Ali Berkin; Walter A Szarek; Robert Kisilevsky
Journal:  Glycoconj J       Date:  2005-11       Impact factor: 3.009

10.  Peracetylated 4-fluoro-glucosamine reduces the content and repertoire of N- and O-glycans without direct incorporation.

Authors:  Steven R Barthel; Aristotelis Antonopoulos; Filiberto Cedeno-Laurent; Lana Schaffer; Gilberto Hernandez; Shilpa A Patil; Simon J North; Anne Dell; Khushi L Matta; Sriram Neelamegham; Stuart M Haslam; Charles J Dimitroff
Journal:  J Biol Chem       Date:  2011-04-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.